Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients

doi:10.3748/wjg.v18.i32.4391

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4223)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

504

HTML

3449

Figures (1-1)

131

Tables (1-4)

139

Sum=4223

Aug 28, 2012 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (72)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2012; 18(32): 4391-4398
Published online Aug 28, 2012. doi: 10.3748/wjg.v18.i32.4391

Open in New Tab Full Size Figure Download Figure

Figure 1 Concordance after ileocolonic resection for Crohn’s disease. A: Between clinical-endoscopic recurrence; B: Between clinical-morphological recurrence. MR: Magnetic resonance; MR0-MR3: A 4-point MR-enteroclysis-based score; i0-i4: A 5-point score to measure the presence and severity of endoscopic lesions in the neoterminal ileum and anastomosis.

Citation: Aguas M, Bastida G, Cerrillo E, Beltrán B, Iborra M, Sánchez-Montes C, Muñoz F, Barrio J, Riestra S, Nos P. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J Gastroenterol 2012; 18(32): 4391-4398
URL: https://www.wjgnet.com/1007-9327/full/v18/i32/4391.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i32.4391